Selective inhibition of soluble tumor necrosis factor signaling reduces abdominal aortic aneurysm progression

The Role of Non-Selective TNF Inhibitors in Demyelinating Events

(2021) Line Buch Kristensen et al.   Brain Sciences

Hyperlipidemia does not affect development of elastase-induced abdominal aortic aneurysm in mice

(2020) Joscha Mulorz et al.   ATHEROSCLEROSIS

Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism

(2019) Yannick Degboé et al.   Frontiers in Immunology

TNF deficiency causes alterations in the spatial organization of neurogenic zones and alters the number of microglia and neurons in the cerebral cortex

(2019) Minna Yli-Karjanmaa et al.   BRAIN BEHAVIOR AND IMMUNITY

Topical Administration of a Soluble TNF Inhibitor Reduces Infarct Volume After Focal Cerebral Ischemia in Mice

(2019) Minna Yli-Karjanmaa et al.   Frontiers in Neuroscience

Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer’s disease associated with obesity, metabolic syndrome, and type 2 diabetes

(2019) Maria Elizabeth De Sousa Rodrigues et al.   Alzheimers Research & Therapy

Soluble TNFα Signaling within the Spinal Cord Contributes to the Development of Autonomic Dysreflexia and Ensuing Vascular and Immune Dysfunction after Spinal Cord Injury

(2018) Eugene Mironets et al.   JOURNAL OF NEUROSCIENCE

STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

(2018) Damian Szklarczyk et al.   NUCLEIC ACIDS RESEARCH

Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice

(2017) Kathryn P. MacPherson et al.   NEUROBIOLOGY OF DISEASE

Constitutive smooth muscle tumour necrosis factor regulates microvascular myogenic responsiveness and systemic blood pressure

(2017) Jeffrey T. Kroetsch et al.   Nature Communications

Anti-inflammatory effects of infliximab in mice are independent of tumour necrosis factor α neutralization

(2016) B. M. Assas et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Soluble TNF Regulates TACE via AP-2α Transcription Factor in Mouse Dendritic Cells

(2016) Lisheng Ge et al.   JOURNAL OF IMMUNOLOGY

Elastin-Derived Peptides Promote Abdominal Aortic Aneurysm Formation by Modulating M1/M2 Macrophage Polarization

(2016) Matthew A. Dale et al.   JOURNAL OF IMMUNOLOGY

Analysis of ADAM17 Polymorphisms and Susceptibility to Sporadic Abdominal Aortic Aneurysm

(2014) You Li et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease

(2014) Han-Yun Hsiao et al.   HUMAN MOLECULAR GENETICS

Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia

(2014) Bettina Hjelm Clausen et al.   Journal of Neuroinflammation

Central but not systemic administration of XPro1595 is therapeutic following moderate spinal cord injury in mice

(2014) Hans G Novrup et al.   Journal of Neuroinflammation

TNF-α blockade induces IL-10 expression in human CD4+ T cells

(2014) Hayley G. Evans et al.   Nature Communications

Critical role of TNF-alpha-TNFR1 signaling in intracranial aneurysm formation

(2014) Tomohiro Aoki et al.   Acta Neuropathologica Communications

Fibrinogen-specific antibody induces abdominal aortic aneurysm in mice through complement lectin pathway activation

(2013) H.-f. Zhou et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Proteomic analysis of the abdominal aortic aneurysm wall

(2013) Jiri Molacek et al.   SURGERY TODAY

Opportunities in Abdominal Aortic Aneurysm Research: Epidemiology, Genetics, and Pathophysiology

(2012) Helena Kuivaniemi et al.   ANNALS OF VASCULAR SURGERY

Interleukin-5 is a potential mediator of angiotensin II-induced aneurysm formation in apolipoprotein E knockout mice

(2012) Jun Xu et al.   JOURNAL OF SURGICAL RESEARCH

Tumor necrosis factor-α converting enzyme is a key mediator of abdominal aortic aneurysm development

(2011) Hidehiro Kaneko et al.   ATHEROSCLEROSIS

Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination

(2011) Roberta Brambilla et al.   BRAIN

Precision Measurement of theBe7Solar Neutrino Interaction Rate in Borexino

(2011) G. Bellini et al.   PHYSICAL REVIEW LETTERS

Tumor Necrosis Factor Receptor Expression and Signaling in Renal Cell Carcinoma

(2010) Rafia S. Al-Lamki et al.   AMERICAN JOURNAL OF PATHOLOGY

Transmembrane TNF- : structure, function and interaction with anti-TNF agents

(2010) T. Horiuchi et al.   RHEUMATOLOGY

Plasma Fibrinogen and D-dimer Concentrations are Associated with the Presence of Abdominal Aortic Aneurysm: A Systematic Review and Meta-analysis

(2009) H. Takagi et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Blocking TNF-  Attenuates Aneurysm Formation in a Murine Model

(2009) W. Xiong et al.   JOURNAL OF IMMUNOLOGY

Tumor necrosis factor-α antagonist use and heart failure in elderly patients with rheumatoid arthritis

(2008) Soko Setoguchi et al.   AMERICAN HEART JOURNAL

Medical Management of Small Abdominal Aortic Aneurysms

(2008) B. Timothy Baxter et al.   CIRCULATION

Update on medication-induced peripheral neuropathy

(2008) Louis H. Weimer et al.   Current Neurology and Neuroscience Reports